Cargando…

Challenges and considerations for reproducibility of STARR-seq assays

High-throughput methods such as RNA-seq, ChIP-seq, and ATAC-seq have well-established guidelines, commercial kits, and analysis pipelines that enable consistency and wider adoption for understanding genome function and regulation. STARR-seq, a popular assay for directly quantifying the activities of...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Maitreya, Hossain, Ayaan, Banerjee, Deepro, Praul, Craig Alan, Girirajan, Santhosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234304/
https://www.ncbi.nlm.nih.gov/pubmed/37130797
http://dx.doi.org/10.1101/gr.277204.122
_version_ 1785052459646844928
author Das, Maitreya
Hossain, Ayaan
Banerjee, Deepro
Praul, Craig Alan
Girirajan, Santhosh
author_facet Das, Maitreya
Hossain, Ayaan
Banerjee, Deepro
Praul, Craig Alan
Girirajan, Santhosh
author_sort Das, Maitreya
collection PubMed
description High-throughput methods such as RNA-seq, ChIP-seq, and ATAC-seq have well-established guidelines, commercial kits, and analysis pipelines that enable consistency and wider adoption for understanding genome function and regulation. STARR-seq, a popular assay for directly quantifying the activities of thousands of enhancer sequences simultaneously, has seen limited standardization across studies. The assay is long, with more than 250 steps, and frequent customization of the protocol and variations in bioinformatics methods raise concerns for reproducibility of STARR-seq studies. Here, we assess each step of the protocol and analysis pipelines from published sources and in-house assays, and identify critical steps and quality control (QC) checkpoints necessary for reproducibility of the assay. We also provide guidelines for experimental design, protocol scaling, customization, and analysis pipelines for better adoption of the assay. These resources will allow better optimization of STARR-seq for specific research needs, enable comparisons and integration across studies, and improve the reproducibility of results.
format Online
Article
Text
id pubmed-10234304
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-102343042023-10-01 Challenges and considerations for reproducibility of STARR-seq assays Das, Maitreya Hossain, Ayaan Banerjee, Deepro Praul, Craig Alan Girirajan, Santhosh Genome Res Perspective High-throughput methods such as RNA-seq, ChIP-seq, and ATAC-seq have well-established guidelines, commercial kits, and analysis pipelines that enable consistency and wider adoption for understanding genome function and regulation. STARR-seq, a popular assay for directly quantifying the activities of thousands of enhancer sequences simultaneously, has seen limited standardization across studies. The assay is long, with more than 250 steps, and frequent customization of the protocol and variations in bioinformatics methods raise concerns for reproducibility of STARR-seq studies. Here, we assess each step of the protocol and analysis pipelines from published sources and in-house assays, and identify critical steps and quality control (QC) checkpoints necessary for reproducibility of the assay. We also provide guidelines for experimental design, protocol scaling, customization, and analysis pipelines for better adoption of the assay. These resources will allow better optimization of STARR-seq for specific research needs, enable comparisons and integration across studies, and improve the reproducibility of results. Cold Spring Harbor Laboratory Press 2023-04 /pmc/articles/PMC10234304/ /pubmed/37130797 http://dx.doi.org/10.1101/gr.277204.122 Text en © 2023 Das et al.; Published by Cold Spring Harbor Laboratory Press https://creativecommons.org/licenses/by-nc/4.0/This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see https://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Perspective
Das, Maitreya
Hossain, Ayaan
Banerjee, Deepro
Praul, Craig Alan
Girirajan, Santhosh
Challenges and considerations for reproducibility of STARR-seq assays
title Challenges and considerations for reproducibility of STARR-seq assays
title_full Challenges and considerations for reproducibility of STARR-seq assays
title_fullStr Challenges and considerations for reproducibility of STARR-seq assays
title_full_unstemmed Challenges and considerations for reproducibility of STARR-seq assays
title_short Challenges and considerations for reproducibility of STARR-seq assays
title_sort challenges and considerations for reproducibility of starr-seq assays
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234304/
https://www.ncbi.nlm.nih.gov/pubmed/37130797
http://dx.doi.org/10.1101/gr.277204.122
work_keys_str_mv AT dasmaitreya challengesandconsiderationsforreproducibilityofstarrseqassays
AT hossainayaan challengesandconsiderationsforreproducibilityofstarrseqassays
AT banerjeedeepro challengesandconsiderationsforreproducibilityofstarrseqassays
AT praulcraigalan challengesandconsiderationsforreproducibilityofstarrseqassays
AT girirajansanthosh challengesandconsiderationsforreproducibilityofstarrseqassays